BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 37446782)

  • 21. Preclinical Evaluation of a Novel High-Affinity Radioligand [
    Bezverkhniaia E; Kanellopoulos P; Abouzayed A; Larkina M; Oroujeni M; Vorobyeva A; Rosenström U; Tolmachev V; Orlova A
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139219
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preparation, Biological Evaluation, and First-in-Human Single-Photon Emission Computed Tomography (SPECT) Study of
    Xiao D; Han P; Jiang Y; Duan X; Ruan Q; Zhang Z; Chen X; Zhang J
    ACS Pharmacol Transl Sci; 2024 May; 7(5):1335-1347. PubMed ID: 38751628
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [
    Vats K; Chakraborty A; Rakshit S; Damle A; Sarma HD; Satpati D
    Nucl Med Biol; 2023; 118-119():108331. PubMed ID: 36933456
    [TBL] [Abstract][Full Text] [Related]  

  • 24. (99m)Tc-labeled dimeric octreotide peptide: a radiotracer with high tumor uptake for single-photon emission computed tomography imaging of somatostatin receptor subtype 2-positive tumors.
    Dong C; Zhao H; Yang S; Shi J; Huang J; Cui L; Zhong L; Jin X; Li F; Liu Z; Jia B; Wang F
    Mol Pharm; 2013 Aug; 10(8):2925-33. PubMed ID: 23768172
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of (99m)Tc-HYNIC-TMTP1 as a tumor-homing imaging agent targeting metastasis with SPECT.
    Li F; Cheng T; Dong Q; Wei R; Zhang Z; Luo D; Ma X; Wang S; Gao Q; Ma D; Zhu X; Xi L
    Nucl Med Biol; 2015 Mar; 42(3):256-62. PubMed ID: 25516099
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Kit preparation and biokinetics in women of 99mTc-EDDA/HYNIC-E-[c(RGDfK)]2 for breast cancer imaging.
    Ortiz-Arzate Z; Santos-Cuevas CL; Ocampo-García BE; Ferro-Flores G; García-Becerra R; Estrada G; Gómez-Argumosa E; Izquierdo-Sánchez V
    Nucl Med Commun; 2014 Apr; 35(4):423-32. PubMed ID: 24335877
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiolabeled Rhein as Small-Molecule Necrosis Avid Agents for Imaging of Necrotic Myocardium.
    Luo Q; Jin Q; Su C; Zhang D; Jiang C; Fish AF; Feng Y; Ni Y; Zhang J; Yin Z
    Anal Chem; 2017 Jan; 89(2):1260-1266. PubMed ID: 27981843
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design and evaluation of new Tc-99m-labeled lactam bridge-cyclized alpha-MSH peptides for melanoma imaging.
    Guo H; Gallazzi F; Miao Y
    Mol Pharm; 2013 Apr; 10(4):1400-8. PubMed ID: 23418722
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development and Characterization of
    Bolzati C; Gobbi C; Ferro-Flores G; Turato S; Ocampo-Garcia B; Carpanese D; Marzano C; Spolaore B; Fracasso G; Rosato A; Meléndez-Alafort L
    Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203663
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Pretargeted Imaging Strategy for Immune Checkpoint Ligand PD-L1 Expression in Tumor Based on Bioorthogonal Diels-Alder Click Chemistry.
    Qiu L; Tan H; Lin Q; Si Z; Mao W; Wang T; Fu Z; Cheng D; Shi H
    Mol Imaging Biol; 2020 Aug; 22(4):842-853. PubMed ID: 31741201
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and pre-clinical evaluation of a new class of high-affinity
    Kelly J; Amor-Coarasa A; Nikolopoulou A; Kim D; Williams C; Ponnala S; Babich JW
    Eur J Nucl Med Mol Imaging; 2017 Apr; 44(4):647-661. PubMed ID: 27847991
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [
    Maurin M; Wyczółkowska M; Sawicka A; Sikora AE; Karczmarczyk U; Janota B; Radzik M; Kłudkiewicz D; Pijarowska-Kruszyna J; Jaroń A; Wojdowska W; Garnuszek P
    Molecules; 2022 Oct; 27(21):. PubMed ID: 36364046
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic sensitivity of Tc-99m HYNIC PSMA SPECT/CT in prostate carcinoma: A comparative analysis with Ga-68 PSMA PET/CT.
    Lawal IO; Ankrah AO; Mokgoro NP; Vorster M; Maes A; Sathekge MM
    Prostate; 2017 Aug; 77(11):1205-1212. PubMed ID: 28649735
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of a New
    Farahani AM; Maleki F; Sadeghzadeh N; Abediankenari S; Abedi SM; Erfani M
    Anticancer Agents Med Chem; 2020; 20(14):1695-1703. PubMed ID: 32560611
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Novel Radioimmune
    Ye M; Gai Y; Ji H; Jiang Y; Qiao P; Wang W; Zhang Y; Xia X; Lan X
    Front Immunol; 2021; 12():660842. PubMed ID: 34484174
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Introduction of an 8-aminooctanoic acid linker enhances uptake of 99mTc-labeled lactam bridge-cyclized α-MSH peptide in melanoma.
    Guo H; Miao Y
    J Nucl Med; 2014 Dec; 55(12):2057-63. PubMed ID: 25453052
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radiation Dosimetry of
    Urbán S; Meyer C; Dahlbom M; Farkas I; Sipka G; Besenyi Z; Czernin J; Calais J; Pávics L
    J Nucl Med; 2021 Aug; 62(8):1075-1081. PubMed ID: 33277398
    [No Abstract]   [Full Text] [Related]  

  • 38. Generation and characterization of nanobodies targeting PSMA for molecular imaging of prostate cancer.
    Evazalipour M; D'Huyvetter M; Tehrani BS; Abolhassani M; Omidfar K; Abdoli S; Arezumand R; Morovvati H; Lahoutte T; Muyldermans S; Devoogdt N
    Contrast Media Mol Imaging; 2014; 9(3):211-20. PubMed ID: 24700748
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exendin-4-based radiopharmaceuticals for glucagonlike peptide-1 receptor PET/CT and SPECT/CT.
    Wild D; Wicki A; Mansi R; Béhé M; Keil B; Bernhardt P; Christofori G; Ell PJ; Mäcke HR
    J Nucl Med; 2010 Jul; 51(7):1059-67. PubMed ID: 20595511
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.